Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT ID: NCT00100295
Last Updated: 2007-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
59 participants
INTERVENTIONAL
2005-02-28
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will last 9 weeks. Participants will be randomly assigned to receive either an herbal product or placebo three times a day for the duration of the study. Participants will come in for weekly study visits at which their ADHD symptoms and any side effects will be assessed by self-report rating scales.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Herbal treatment
Hypericum perforatum
300 mg capsule taken three times a day
B
Placebo
300 mg given three times a day, containing rice protein powder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypericum perforatum
300 mg capsule taken three times a day
Placebo
300 mg given three times a day, containing rice protein powder
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score of greater than 1.5 standard deviation above the age and gender norms on the ADHD-IV rating scale
* Parents and children can understand English
* Parents and children willing to attend all study visits
* Able to swallow study medication
* Willing to use acceptable methods of contraception
Exclusion Criteria
* History of bipolar disorder, psychosis, severe conduct disorder, or other serious medical conditions
* Use of medications that may interact with the herbal product
* Current use of medications to treat ADHD
* Previous use of Hypericum
* Pregnancy
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wendy Weber, ND, MPH
Role: PRINCIPAL_INVESTIGATOR
Bastyr University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bastyr University
Kenmore, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weber W, Vander Stoep A, McCarty RL, Weiss NS, Biederman J, McClellan J. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA. 2008 Jun 11;299(22):2633-41. doi: 10.1001/jama.299.22.2633.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.